Ewha Womans University Medical Center
The cost of chemotherapy for brain tumor in South Korea typically ranges from $1,300 to $2,700. Prices vary depending on the type of chemotherapy drugs, the number of cycles, the hospital, and the oncologist’s experience. In the United States, the average cost is $30,000 (per American Cancer Society). Chemotherapy for brain tumor in South Korea is about 93% less than in the U.S.
South Korean clinics usually include the initial consultation, pre-treatment blood tests, post-treatment medications, follow-up visits, English-speaking support, personalized care plans, and meals during clinic visits. In the U.S., costs often cover only the drugs and administration, with separate charges for labs, consultations, and aftercare. Always confirm exactly what each clinic’s package includes.
| Republic of Korea | Turkey | Austria | |
| Chemotherapy for Brain Tumor | from $1,338 | from $1,000 | from $12,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Chemotherapy for Brain Tumor upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemotherapy for Brain Tumor and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemotherapy for Brain Tumor journey.
Day 1: Arrival
Day 2-3: Pre-operation
Day 4-5: Chemotherapy for Brain Tumor
Day 6: Post-operation
Week 1-2: Rehabilitation
Week 3: Return to Normal Activities
Week 4: Final Result
Please note that the timeline and process can vary depending on individual circumstances and the specifics of the brain tumor. Always consult with your healthcare team for advice tailored to your situation.
Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital are the top destinations for brain tumor chemotherapy in South Korea. These JCI-accredited facilities integrate advanced systemic therapies with proton therapy and multidisciplinary neuro-oncology teams to treat over 2,000 cases annually.
Bookimed Expert Insight: While many focus on surgery, South Korea’s secret weapon is high-volume efficiency. Asan Medical Center manages 2,500+ daily inpatients, which translates to shorter chemotherapy wait times. Patients often start cycles within 2 weeks, significantly faster than in many Western healthcare systems.
Patient Consensus: Patients value the rapid MRI monitoring at Severance Hospital for catching complications early. Families also highlight the success of lower-dose regimens at SNUH for minimizing neurotoxicity during treatment.
Korean clinics follow standardized protocols using Temozolomide as the primary oral chemotherapy for high-grade gliomas. Other essential treatments include the PCV regimen (Procarbazine, Lomustine, and Vincristine) for low-grade gliomas and Bevacizumab for recurrent cases. Major centers also utilize Carmustine wafers during surgical tumor resection.
Bookimed Expert Insight: While standard protocols match international guidelines, top Seoul clinics like Asan Medical Center and Severance Hospital often use dose-intensification for younger patients. These facilities frequently combine standard chemotherapy with advanced digital imaging and AI-driven monitoring. This integration helps oncologists adjust dosage in real-time based on immediate tumor response data.
Patient Consensus: Patients value the rapid access to clinical trials and advanced genetic testing for personalized dosing. Many recommend hiring a medical translator to ensure clear communication regarding complex side effect management during long-term cycles.
South Korea reports a 5-year relative survival rate of 86.4% for all primary brain and central nervous system tumors. Malignant brain tumor survival reaches 44.1%, while non-malignant cases show 91.8%. Specialized centers like Severance Hospital and Asan Medical Center utilize advanced genomic testing to protocols.
Bookimed Expert Insight: High survival rates in Seoul stem from massive patient volumes at centers like Severance Hospital. This facility treats 1.6 million outpatients annually. This intensity allows surgeons to refine techniques for rare tumors. This experience often leads to outcomes exceeding global averages for mid-grade astrocytomas.
Patient Consensus: Patients value the routine use of MGMT and IDH testing for precise chemotherapy targeting. Many report that survival gains for low-grade tumors make navigating the long treatment cycles worthwhile.
International patients can travel home between chemotherapy sessions if they are medically stable and cleared by their South Korean oncology team. Feasibility depends on your specific treatment cycle, flight duration, and blood count stability, particularly during the 7 to 12-day post-infusion nadir period.
Bookimed Expert Insight: While Temozolomide protocols in Seoul offer some flexibility, the sheer volume of patients at centers like Asan Medical Center or Severance Hospital means follow-up slots are tight. Coordination is key because missing a 1-week post-infusion check can delay your entire regimen. We recommend booking premium economy to lie flat, as brain tumor patients face higher risks of swelling during pressure changes.
Patient Consensus: Patients emphasize carrying double the required seizure medication and securing a local neuro-oncologist at home for interim bloodwork. Managing visa extensions in Korea is also vital to avoid legal issues during multi-month treatment cycles.